European UPC Ruling Refuses Block On Soliris Biosimilars

Court Values Alexion’s Disputes With Amgen And Samsung At €100m Apiece

 
• By Dave Wallace
  
The UPC’s Court of Appeal refused injunctions (Shutterstock)

More from Biosimilars

More from Generics Bulletin